Guide · 12 min · 2026-08-28
API & Bulk Drug Manufacturing Software Guide: 21 CFR Part 11 DMS, LIMS & EBR
Complete guide to digitizing Active Pharmaceutical Ingredient (API) plants: solvent recovery, yield tracking, LIMS, and digital batch execution.
1. Unique Quality & Operational Challenges in API Chemical Synthesis
Active Pharmaceutical Ingredient (API) and bulk drug manufacturing plants operate complex, continuous, and multi-stage chemical synthesis processes involving raw material dispensing, reaction stages, crystallization, centrifuge separation, drying, milling, and mother liquor/solvent recovery. Managing these workflows on paper creates severe batch reconciliation delays and solvent mass balance discrepancies.
2. Step-Level Digital Execution & Yield Mass Balance in Novaqis BRM
Novaqis BRM digitizes Master Formula Records (MFR) for synthetic chemistry: • In-Process Parameter Gating: Enforcing real-time checks on reactor temperature, pressure, stirring speed, and reflux duration before advancing steps. • Automated Mass Balance Calculations: Real-time calculation of theoretical vs actual yields, recovery percentages, and loss-on-drying (LOD) parameters. • Solvent Recovery & Mother Liquor Tracking: Governed logbooks tracking solvent lot traceability and multi-batch distillation cycles.
3. QC Laboratory Testing & Instrument Acquisition (Novaqis LIMS)
API quality control requires rigorous testing of starting materials, intermediate compounds, and final release batches across HPLC, GC, FTIR, and NMR instrumentation. Novaqis LIMS integrates with chromatography data systems (Empower, Chromeleon) via IDAS IoT middleware, pulling test results directly into certificates of analysis (CoA) without manual transcription.
Experience the Enterprise GxP Suite Live
Discover how Novaqis unifies Document Management (DMS), Quality Management (eQMS), Training (LMS), Laboratory Informatics (LIMS), Batch Records (BRM), and ERP on a single high-availability architecture.